Skip to main content
Providing practical opinion to support best practice for busy healthcare professionals
Connect with us
Information for Authors
Information for Peer Reviewers
European Oncology & Haematology
Oncology & Hematology Review (US)
Pre-IMPAKT 2017 Training Course
ESMO-ESO Course on Medical Oncology for Medical Students 2017: Application
Press Release: Biosimilars Create Opportunities for Sustainable Cancer Care
FDA Approves Bevacizumab Plus Chemotherapy, Followed by Bevacizumab Alone, for the Treatment of Patients with Platinum-Sensitive Recurrent...
FDA Grants Priority Review for Atezolizumab in First-Line Treatment of Patients With Urothelial Carcinoma Who are Not Eligible for...
Tailored scientific advice to support step-by-step development of new biosimilars
King F Kwong
Greenebaum Cancer Center